Contrast-Induced Nephropathy: What has Changed?

CE Accreditation Testing & Evaluation
Successful completion requires a passing grade of 75%.
To view the CE Overview, please click here.

Please click here to complete your evaluation, test, and print your Certificate.

Cedars-Sinai Heart Institute Opens First-of-its-Kind Research Stem Cell Clinic for Cardiac Patients

Physicians to Devise Comprehensive Treatment Strategies, Evaluate Patients for Inclusion in Ongoing Stem Cell Clinical Trials

LOS ANGELES (Aug. 12, 2014) – Regenerative medicine experts at the Cedars-Sinai Heart Institute have opened a new clinic to evaluate heart and vascular disease patients for participation in stem cell medical studies.

ACIST Enters Co-Promotion Agreement with Medtronic to Commercialize Next-Generation FFR and IVUS Technologies in U.S.

Collaboration provides increased commercial reach, brand synergies and customer access to new technologies
 
EDEN PRAIRIE, Minn. (August 4, 2014) – ACIST Medical Systems, Inc., a Bracco Group company offering advanced contrast delivery systems for cardiology, today announced that it has
entered into a strategic agreement with Medtronic, Inc. to co-promote the world’s first Rapid Exchange Fractional Flow Reserve (FFR) (RXi) and High Definition Intravascular Ultrasound (IVUS) (HDi) technologies in the United States. Under this

Earlier Intervention for NSTEMI Linked to Improved Survival Rates

August 4, 2014 — Changes in the treatment of the most common form of heart attack over the past decade have been associated with higher survival rates for men and women regardless of age, race and ethnicity, according to a UCLA-led analysis. But the study also suggests that there is room for improvement in how current treatment guidelines are applied among specific patient groups.

Volume 26 - Issue 8 - August 2014

Volume Number: 
26
Issue Number: 
8
Journal Date: 
August 2014
Supplement: 
uniqueID: 
268

Polypill Strategy May Improve Global Secondary Cardiovascular Prevention

Review shows polypill approach may overcome barriers to compliance, reduce costs

WASHINGTON (Aug. 4, 2014) — The polypill, a combination pill taken just once a day that includes key medications for secondary prevention of heart disease, may be an effective low-cost strategy to improve adherence to medication recommendations and reduce costs, according to researchers from Spain and New York, who reviewed research on the polypill.

Societies Mark 30 Years of Guidelines for Evidence-Based Cardiovascular Care

ACC/AHA review, update process for producing clinical practice guidelines

August 4, 2014 — Marking the 30th anniversary of the publication of their first joint guidelines for the diagnosis and treatment of heart disease, the American College of Cardiology and the American Heart Association today published an extensive review of the process and methodology for evaluating cardiovascular research and writing practice guidelines for clinicians.

ACC/AHA Release Updated Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

(Aug. 1, 2014) —The American College of Cardiology and the American Heart Association today released a revised guideline for minimizing the risk of cardiovascular complications around the time of noncardiac surgery after conducting a new review of research and reevaluating data from a controversial trial about the use of beta-blockers before surgery.

Back to top